Role of N-acetyl-beta-D-hexosaminidase in cholesteatoma tissue

• Autorzy: Olszewska E. , Olszewski S. , Borzym-Kluczyk M. , Zwierz K.
• Języki publikacji: EN

Abstrakty

EN

Cholesteatoma is a destructive disease characterized by the progressive expansion of keratinizing squamous epithelium in the middle ear and mastoid, and chronic inflammatory reaction of the subepithelial connective tissue. N-Acetyl-β-d-hexosaminidase (HEX) catalyzes the release of terminal non-reducing N-acetyl-d-hexosamine residues acting on glucosides and galactosides in glycoproteins, GM2-gangliosides and glycosaminoglycans (GAGs). In this study the activities of HEX were measured in cholesteatoma tissue and in normal skin to demonstrate a possible role of HEX in bone resorption in the area adjacent to cholesteatoma. Cholesteatomas (n = 21) and normal adult retroauricular skin (controls, n = 21), were collected from patients during surgery due to chronic otitis media. In 20 of 21 specimens a significantly higher activity of HEX was observed in cholesteatoma tissue compared with that in normal skin. Mean release of HEX from the activated cells was 68.55 ± 30.77 nkat/g wet tissue in cholesteatoma and 31.79 ± 10.02 nkat/g wet tissue in skin specimens. It may explain the process of bone resorption in the area adjacent to cholesteatoma, i.e. ossicles or temporal bone. This study suggests that drugs inhibiting HEX activity, such as iminocyclitols, may be useful in cholesteatoma treatment.

Słowa kluczowe

EN

connective tissue; glucoside; human disease; activity; glycoprotein; glycosaminoglycan; cholesteatoma; treatment; normal skin; galactoside; N-acetyl-beta-D-hexosaminidase

• Wydawca: -
• Czasopismo: Acta Biochimica Polonica
• Rocznik: 2007
• Tom: 54
• Numer: 2
• Opis fizyczny: p.365-370,fig.,ref.

Twórcy

autor

Olszewska E.

• Medical University of Bialystok, Sklodowskiej 24A, 15-276 Bialystok, Poland

autor

Olszewski S.

autor

Borzym-Kluczyk M.

autor

Zwierz K.

Bibliografia

• Albino AP, Kimmelman CP, Parisier SC (1998) Cholesteatoma: a molecular and cellular puzzle. Am J Otol 19: 7–19.
• Arciuch LP, Bielecki D, Borzym M, Poludniewski G, Arciszewki K, Rozanski A, Zwierz K (1999) Isoenzymes of N-acetyl-β-hexosaminidase in complicated pregnancy. Acta Biochim Polon 46: 977–983.
• Baram D, Vaday GG, Salamon P, Drucker H, Hershkoviz R, Mekori YA (2001) Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-α. J Immunol 167: 4008–4016.
• Baritussio A, Marzini S, Agostini M, Alberti A, Cimenti C, Bruttomesso D (2001) Amiodarone inhibits lung degradation of SP-A and perturbs the distribution of lysosomal enzymes. Am J Physiol Lung Cell Mol Physiol 281: L1189–L1199.
• Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, D’Amico G (2002) Urinary N-acetyl-β-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transplant 17: 1890–1896.
• Berenbaum F, Le Gars L, Toussirot E, Sanon A, Bories C, Kaplan G, Loiseau PM (2000) Marked elevation of serum N-acetyl-β-d-hexosaminidase activity in rheumatoid arthritis. Clin Exp Rheumatol 18: 63–66.
• Bhuvarahamurthy V, Govindsamy S (1996) Purification and characterization of hexosaminidase from human uterine cervical carcinoma. Gynecol Oncol 60: 188–196.
• Blair H, Kahn AJ, Sadow J, Malone JD, Teitelbaum SL (1981) Disassociation of lysosomal enzyme secretion and macrophage-mediated bone resorption. Biochem Biophys Res Commun 100: 959–964.
• Bujia J, Kim C, Ostos P, Kastenbauer E, Hultner L (1996) Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatoma. Eur Arch Otorhinolaryngol 253: 152–157.
• Casal JA, Cano E, Tutor JC (2005) β-hexosaminidase isoenzyme profiles in serum, plasma, platelets and mononuclear, polymorphonuclear and unfractionated total leukocytes. Clin Biochem 38: 938–942.
• Chatterjee S, Velicer LF, Sweeley CC (1975) Glycosphingolipid glycosyl hydrolases and glycosidases of synchronized human KB cells. J Biol Chem 250: 4972–4979.
• Chodynicki S, Chyczewski L, Olszewska E (2002) Immunohistochemical investigations of cathepsin D activity in the structures of cholesteatoma. Med Sci Monit 8: BR184–BR186.
• Chole RA, Hughes RM, Faddis BT (2001) Keratin particle–induced osteolysis: A mouse model of inflammatory bone remodeling related to cholesteatoma. J Assoc Res Otolaryngol 2: 65–71.
• Chole RA, Tinling SP, Faddis BT (1994) Human recombinant interleukin-1 receptor antagonist blocks bone resorption induced by interleukin-1 alpha. Calcif Tissue Int 55: 12–15.
• Cynamon U, Kronenberg J, Benayahu D (2000) Structural changes and protein expression in the mastoid bone adjacent to cholesteatoma. Laryngoscope 110: 1198–1203.
• Dinarello CA (1996) Biological basis for interleukin-1 in disease. Blood 87: 2095–2147.
• du Verney JG (1683) Traite de l’organe de l’ouie, contenant structure. Les ufages et leas maladies des toutes les parties de l’orelle. E. Michallet, Paris.
• Elsafi ME, Isaksson A, Stenraum U (1992) Immunohistochemical studies of β-hexosaminidase in neoplastic and normal tissues with monoclonal antibodies. APMIS 100: 360–366.
• Elsafi ME, Hultberg B, Isaksson A, Hagerstrand J, Prytz H, Stenram U (1994) Lysosomes and human liver disease: a biochemical and immunohistochemical study of β-hexosaminidase. Eur J Clin Chem Clin Biochem 32: 669–673.
• Emiliani C, Sciarra R, Orlacchio A, Stirling JL (1999) β-Nacetylhexosaminidases in the spleen of a patient with hairy-cell leukemia. Biochim Biophys Acta 1037: 265–273.
• Fox SW, Kuller K, Chambers TJ (2000) Activation of osteoclasts by interleukin-1: Divergent responsiveness in osteoclasts formed in vivo and in vitro. J Cell Physiol 184: 334–340.
• Galli SJ (1993) New concept about the mast cell. N Engl J Med 328: 257–265.
• Gil-Martin E, Rodriguez-Berrocal FJ, Paez de la Cadena M, Fernandez-Briera A (1999) N-acetyl-β-hexosaminidase activity and isoenzymes in human gastric adenocarcinoma. Oncology 56: 142–154.
• Goldring SR, Gravallese EM (2000) Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol 12: 195–199.
• Hammarsund M, Lerner M, Zhu C, Merup M, Jansson M, Gahrton G, Kluin-Nelemans H, Einhorn S, Grander D, Sangfelt O, Corcoran M (2004) Disruption of a novel ectodermal neural cortex 1 antisense gene, ENC–1AS and identification of ENC-1 overexpression in hairy cell leukemia. Hum Mol Genet 13: 2925–2936.
• Harvima IT, Horsmanheimo L, Naukkarinen A, Horsmanheimo M (1994) Mast cell proteinases and cytokines in skin inflammation. Arch Dermatol Res 287: 61–67.
• Hebda PA, Collins MA, Tharp MD (1993) Mast cell and myofibroblast in wound healing. Dermatol Clin 11: 685–696.
• Hochstrasser K, Albrecht GJ, Gebhard W, Rasp G, Kastenbauer E (1994) Isolation and characterization of trypsinlike and chymotrypsin-like proteinases from human cholesteatoma. Eur Arch Otorhinolaryngol 251: 30–35.
• Ichisaka S, Ohno K, Yuasa I, Nanba E, Sakuraba H, Suzuki Y (1998) Increased expression of β-hexosaminidase alpha chain in cultured skin fibroblasts from patients with carbohydrate-deficient glycoprotein syndrome type I. Brain Dev 20: 302–306.
• Jung JY, Chole RA (2002) Bone resorption in chronic otitis media: the role of the osteoclast. ORL J Otorhinolaryngol Relat Spec 64: 95–107.
• Kato A, Ohashi Y, Masamoto T, Sakamoto H, Uekawa M, Nakai Y (1998) Interleukin-6 and tumor necrosis factor alpha synthesized by cholesteatoma cells affect mucociliary function in the Eustachian tube. Acta Otolaryngol Suppl 538: 90–97.
• Kim CS, Lee CH, Chung JW, Kim CD (1996) Interleukin-1 alpha, interleukin-1 beta and interleukin-8 gene expression in human aural cholesteatomas. Acta Otolaryngol 116: 302–306.
• Kinane DF, Lappin DF (2001) Clinical, pathological and immunological aspects of periodontal disease. Acta Odontol Scand 59: 154–160.
• Kotanko P, Margreiter R, Pfaller W (1996) Reduced renal allograft survival is related to low urinary N-acetyl-β-d-glucosaminidase excretion during the first posttransplant month. Transplantation 61: 388–392.
• Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL (2000) TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages expose to permissive levels of RANK ligano. J Clin Invest 106: 1481–1488.
• Lee DM, Weinblatt ME (2001) Rheumatoid arthritis. Lancet 358: 903–911.
• Lerner UH (1996) Transforming growth factor-beta stimulates bone resorption in neonatal moouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway. J Bone Miner Res 11: 1628–1639.
• Linko-Lopponen S (1986) Fluorimetric measurement of urinary N-acetyl-β-glucosaminidase and its correlation to uremia. Clin Chim Acta 169: 123–127.
• Liu J, Numa MM, Liu H, Huang SJ, Sears P, Shikhman AR, Wong CH (2004) Synthesis and high-throughput screening of N-acetyl-β-hexosaminidase inhibitor libraries targeting osteoarthritis. J Org Chem 69: 6273–6283.
• Matsuura T, Uematsu T, Yamaoka M, Furusawa K (2004) Effect of salivary gland adenocarcinoma cell-derived alpha-N-acetylgalactosaminidase on the bioactivity of macrophage activating factor. Int J Oncol 24: 521–528.
• Michaels L, Hellequist HB (2001) Ear, nose and throat histopathology, Springer, London, Heidelberg, New York.
• Minami R, Wagatsuma K, Ishikawa Y, Watanabe M, Nakao T, Tsugawa S (1985) Comparative enzymology of eleven acid hydrolases in cultured amniotic fluid cells, skin fibroblasts and embryonic lung fibroblasts, and the respective changes with the increasing age of the cell cultures. Tohoku J Exp Med 145: 437–445.
• Nakazawa M, Tamai M (1991) Lysosomal acid hydrolases in vitreous fluid of patients with proliferative diabetic retinopathy. Jpn J Ophthalmol 35: 331–338.
• Olszewska E, Chodynicki S, Chyczewski L (2003) Evaluation of epithelial proliferation and apoptosis in cholesteatoma of adults. Otolaryngol Pol 57: 85–89.
• Olszewska E, Chodynicki S, Chyczewski L (2004) Role of angiogenesis in the pathogenesis of cholesteatoma in adults. Otolaryngol Pol 58: 559–563.
• Olszewska E, Lautermann J, Koc C, Schwaab M, Dazert S, Hildmann H, Sudhoff H (2005) Cytokeratin expression pattern in congenital and acquired pediatric cholesteatoma. Eur Arch Otorhinolaryngol 262: 751–756.
• Olszewska E, Borzym-Kluczyk M, Olszewski S, Rogowski M, Zwierz K (2006a) Hexosaminidase as a new potential marker for middle ear cholesteatoma. Clin Biochem 39: 1088–1090.
• Olszewska E, Chodynicki S, Chyczewski L (2006b) Some markers of proliferative activity in cholesteatoma epithelium in adults. Med Sci Monit 12: CR1–CR4.
• Olszewska E, Chodynicki S, Chyczewski L (2006c) Apoptosis in the pathogenesis of cholesteatoma in adults. Eur Arch Otorhinolaryngol 263: 409–413.
• Perez-Blanco FJ, Ruiz-Martin A, Moreno-Terribas G, Cantero- Hinojosa J (1996) Urinary activity of N-acetyl-β-glycosaminidase (NAG) in arterial hypertension. Clin Nephrol 45: 65–66.
• Popko J, Zalewska A, Olszewski S, Gorska A, Sierakowski S, Zwierz K, Urban M (2003) Activity of N-acetyl-β-hexosaminidase in serum and joint fluid of the knees of patients with juvenile idiopatic arthritis. Clin Exp Rheumatol 21: 675.
• Popko J, Zalewska A, Golaszewska Z, Marciniak J, Sierakowski S, Worowski K, Zwierz K (2005) Comparative analysis of hexosaminidase and cathepsin D expression in synovial fluid of patients with rheumatoid arthritis and traumatized joints. Clin Exp Rheumatol 23: 725–726.
• Reed JA, Albino AP, McNutt NS (1995) Human cutaneous mast cells express basic fibroblast growth factor. Lab Invest 72: 215–222.
• Rye CS, Withers SG (2000) Glycosidase mechanisms. Curr Opin Chem Biol 4: 573–580.
• Schwartz LB, Austen KF (1980) Enzymes of the mast cell granule. J Invest Dermatol 74: 349–353.
• Shikhman AR, Brinson DC, Lotz M (2000) Profile of glycosaminoglycan-degrading glycosidases and glycoside sulfatases secreted by human articular chondrocytes in homeostasis and inflammation. Arthritis Rheum 43: 1307–1314.
• Shiwa M, Kojima H, Moriyama H (1998) Expression of transforming growth factor-alpha (TGF-alpha) in cholesteatoma. J Laryngol Otol 112: 750–754.
• Sinnott M (1990) Catalytic mechanism of enzymic glycosyl transfer. Chem Rev 90: 1171–1202.
• Skalova S (2005) The diagnostic role of urinary N-acetyl-β-d-glucosaminidase (NAG) activity in the detection of renal tubular impairment. Acta Medica (Hradec Kralove) 48: 75–80.
• Sohar N, Sohar I, Hammer H (2005) Lysosomal enzyme activities: new potential markers for Sjogren’s syndrome. Clin Biochem 38: 1120–1126.
• Stabellini G, Vertemati M, Locci P, Calvitti M, Minola E, Calastrini C, Pellati A, Carinci F, Marinucci L, Lilli C, Baroni T (2005) In vitro human osteoblast and extracellular matrix changes after transforming growth factor beta 1 treatment. Pathology 37: 347–354.
• Tos M (1988) Manual of middle ear surgery. Thieme, Stuttgart, New York.
• Winchester BG (1996) Lysosomal metabolism of glycoconjugates. Subcell Biochem 27: 191–238.
• Zwierz K, Gindzienski A, Ostrowska L, Stankiewicz–Choroszucha B (1989) Metabolism of glycoconjugates in human gastric mucosa — a review. Acta Med Hung 46: 275–288.
• Zwierz K, Zalewska A, Zoch-Zwierz W (1999) Isoenzymes of N-acetyl-β-hexosaminidase. Acta Biochim Polon 46: 739–751.